File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Double-Blind, Placebo-Controlled Trial of Emtricitabine (FTC, EmtrivaR) Administered Once-Daily for Treatment of Chronic Hepatitis B Virus (HBV) Infection

TitleDouble-Blind, Placebo-Controlled Trial of Emtricitabine (FTC, EmtrivaR) Administered Once-Daily for Treatment of Chronic Hepatitis B Virus (HBV) Infection
Authors
Lai, CL
Issue Date2004
PublisherJohn Wiley & Sons, Inc.
Citation
The 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA, 29 October-2 November 2004. In Hepatology, 2004, v. 40 n. S4 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/102272
ISSN
1527-3350
2023 Impact Factor: 12.9
2023 SCImago Journal Rankings: 5.011

 

DC FieldValueLanguage
dc.contributor.authorLai, CLen_HK
dc.date.accessioned2010-09-25T20:23:57Z-
dc.date.available2010-09-25T20:23:57Z-
dc.date.issued2004en_HK
dc.identifier.citationThe 55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA, 29 October-2 November 2004. In Hepatology, 2004, v. 40 n. S4-
dc.identifier.issn1527-3350-
dc.identifier.urihttp://hdl.handle.net/10722/102272-
dc.languageengen_HK
dc.publisherJohn Wiley & Sons, Inc.-
dc.relation.ispartofHepatologyen_HK
dc.titleDouble-Blind, Placebo-Controlled Trial of Emtricitabine (FTC, EmtrivaR) Administered Once-Daily for Treatment of Chronic Hepatitis B Virus (HBV) Infectionen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailLai, CL: hrmelcl@hku.hken_HK
dc.identifier.authorityLai, CL=rp00314en_HK
dc.identifier.hkuros101796en_HK
dc.identifier.issnl0270-9139-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats